Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents (OCTOPUS)

This study has been completed.
B. Braun Melsungen AG
Abbott Vascular
Boston Scientific Corporation
Information provided by (Responsible Party):
Tudor C. Poerner, University of Jena Identifier:
First received: January 25, 2010
Last updated: February 25, 2013
Last verified: February 2013